Advertisement
Advertisement
Vyepti

Vyepti

eptinezumab

Manufacturer:

H. Lundbeck

Distributor:

B L Hua

Marketer:

B L Hua
Concise Prescribing Info
Contents
Eptinezumab
Indications/Uses
Preventive treatment of migraine in adults who have at least 4 migraine days per mth.
Dosage/Direction for Use
IV infusion Recommended dose: 100 mg every 12 wk. Some patients may benefit from 300 mg every 12 wk.
Contraindications
Special Precautions
Discontinue treatment if serious hypersensitivity reaction including anaphylactic reactions occur. Patients w/ history of CV disease (eg, HTN, ischemic heart disease). Not to be used during pregnancy. Lactation. Childn <18 yr.
Adverse Reactions
Nasopharyngitis; hypersensitivity reactions; infusion-related reaction.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD05 - eptinezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Vyepti conc for soln for infusion 100 mg/mL
Packing/Price
1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement